Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluLaval Quadrivalent vs Fluzone Quadrivalent in Children 6-35 Months
NCT02242643Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2014
- Primary completion
- Mar 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of influenza virus vaccine, quadrivalent, split virion in influenza (2 arms), sponsored by GSK. Primary endpoint: Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains. Started Oct 2014; status: completed.
02
Drugs
influenza virus vaccine, quadrivalent, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02242643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242643.